Literature DB >> 22682190

Cutaneous zygomycosis.

Alexandro Bonifaz1, Denisse Vázquez-González, Andrés Tirado-Sánchez, Rosa María Ponce-Olivera.   

Abstract

Cutaneous zygomycosis is a fungal infection caused by zygomycetes that affects the skin. It occurs in uncontrolled diabetic patients and immunosuppressed individuals. It has 2 clinical forms: primary cutaneous zygomycosis and secondary cutaneous zygomycosis. The first is characterized by necrotic lesions and the fungus is usually inoculated by trauma. If diagnosed early, it generally has a good prognosis. Secondary zygomycosis is usually a complication and extension of the rhinocerebral variety that starts as a palpebral fistula and progresses to a necrotic lesion with a poor prognosis. The diagnosis is made by identification of the fungus by direct KOH examination, culture, and biopsy. Treatment for the primary disease is surgical debridement plus amphotericin B. The secondary type is treated with amphotericin B and/or posaconazole.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682190     DOI: 10.1016/j.clindermatol.2011.09.013

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  14 in total

1.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

2.  Primary cutaneous mucormycosis presenting as a giant plaque: uncommon presentation of a rare mycosis.

Authors:  Keshavamurthy Vinay; Ariganesh Chandrasegaran; Amrinder J Kanwar; Uma N Saikia; Harsimran Kaur; M R Shivaprakash; Sunil Dogra
Journal:  Mycopathologia       Date:  2014-05-04       Impact factor: 2.574

3.  Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus.

Authors:  Alexandro Bonifaz; Alberto M Stchigel; Josep Guarro; Esther Guevara; Liliana Pintos; Marta Sanchis; José F Cano-Lira
Journal:  J Clin Microbiol       Date:  2014-10-08       Impact factor: 5.948

Review 4.  Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies.

Authors:  Elizabeth J Polvi; Xinliu Li; Teresa R O'Meara; Michelle D Leach; Leah E Cowen
Journal:  Cell Mol Life Sci       Date:  2015-02-21       Impact factor: 9.261

5.  Fatal-mixed cutaneous zygomycosis-aspergillosis: a case report.

Authors:  Estelle Cateau; Edouard Randriamalala; Antoine Elsendoorn; Jean-Philippe Giot; Christophe Monegier du Sorbier; Marie-Helene Rodier
Journal:  Mycopathologia       Date:  2013-10-02       Impact factor: 2.574

6.  Utility of touch preparation for rapid diagnosis of cutaneous mucormycosis.

Authors:  Nina K Antonov; Randy Tang; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2015-06-08

7.  Aggressive cutaneous zygomycosis caused by Apophysomyces variabilis in an immunocompetent child.

Authors:  Ibrahim A Al-Zaydani; Ahmed M Al-Hakami; Martin R P Joseph; Walid M Kassem; Mohamed K Almaghrabi; Abdalla Nageeb; Mohamed E Hamid
Journal:  Med Mycol Case Rep       Date:  2015-12-13

Review 8.  Cutaneous mucormycosis.

Authors:  Ana Daniela Castrejón-Pérez; Esperanza C Welsh; Ivett Miranda; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 9.  Disseminated Pulmonary with Isolated Muscular Mucormycosis in an Acute Myeloid Leukemia Patient: A Case Report and Literature Review.

Authors:  Mustafa Fadhel; Swapnil V Patel; Edward Liu; Lito Fune; Ethan J Wasserman; Arif Asif
Journal:  Am J Case Rep       Date:  2019-08-16

10.  Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report.

Authors:  G Zuglian; D Ripamonti; A Tebaldi; M Rizzi
Journal:  Med Mycol Case Rep       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.